Over the forecasted period from 2024 to 2028, leukemia mortality among males in the US is expected to exhibit a steady, incremental increase. Year-on-year, the growth in mortality rates appears stable, rising by roughly 0.57% annually. Looking back, the level in 2023 was similar to 2024, maintaining a baseline figure around 14,000 male deaths. The compound annual growth rate (CAGR) over these five years reflects a consistent trend closely adhering to the annual increases.
Future trends to watch for include advancements in medical treatments and early detection methods which could potentially impact leukemia mortality rates. Additionally, demographic shifts and changes in healthcare policies are likely to influence future projections.
